Extrait

To study the effects Pentoxifylline in ESA resistant ESRD patients on haemodialysis. The primary study endpoints is the ESA requirement relative to the Hb level (is there a difference in a randomised placebo controlled cross-over study)?

Critère d'inclusion

• We shall study patients with renal failure on dialysis. We shall particularly focus on patients with evidence of erythopoeitin stimulating agent (ESA) resistance

Liens

• ictrp
• euctr